{
  "id": "PMID:31251474-Snanoudj-2019-SERAC1-proband",
  "subject": {
    "id": "proband",
    "timeAtLastEncounter": {
      "age": {
        "iso8601duration": "P8Y"
      }
    },
    "sex": "MALE",
    "taxonomy": {
      "id": "NCBITaxon:9606",
      "label": "Homo sapiens"
    }
  },
  "phenotypicFeatures": [
    {
      "type": {
        "id": "HP:0001508",
        "label": "Failure to thrive"
      },
      "evidence": [
        {
          "evidenceCode": {
            "id": "ECO:0000033",
            "label": "author statement supported by traceable reference"
          },
          "reference": {
            "id": "PMID:31251474",
            "description": "NM_032861.3:c.202C>T,NP_116250.3:p.(Arg68Ter) and NM_032861.3:c.129-1G>C. The authors report that analysis of mRNA from the patient's fibroblasts by RT\u2010PCR and subsequent sequencing indicated that the splicing site variant results in the skipping of exon 3 (PCR product of 61 bp vs. 100 bp for the wild type [WT]) and a new acceptor site at the beginning of exon 4 (c.131), resulting in a predicted protein with 14 amino acids deleted (codons 31 to 44, RNIIKFTGSLILGG), and the insertion of a serine, without a frameshift."
          }
        }
      ]
    },
    {
      "type": {
        "id": "HP:0003200",
        "label": "Ragged-red muscle fibers"
      },
      "excluded": true,
      "evidence": [
        {
          "evidenceCode": {
            "id": "ECO:0000033",
            "label": "author statement supported by traceable reference"
          },
          "reference": {
            "id": "PMID:31251474",
            "description": "NM_032861.3:c.202C>T,NP_116250.3:p.(Arg68Ter) and NM_032861.3:c.129-1G>C. The authors report that analysis of mRNA from the patient's fibroblasts by RT\u2010PCR and subsequent sequencing indicated that the splicing site variant results in the skipping of exon 3 (PCR product of 61 bp vs. 100 bp for the wild type [WT]) and a new acceptor site at the beginning of exon 4 (c.131), resulting in a predicted protein with 14 amino acids deleted (codons 31 to 44, RNIIKFTGSLILGG), and the insertion of a serine, without a frameshift."
          }
        }
      ]
    },
    {
      "type": {
        "id": "HP:0000648",
        "label": "Optic atrophy"
      },
      "evidence": [
        {
          "evidenceCode": {
            "id": "ECO:0000033",
            "label": "author statement supported by traceable reference"
          },
          "reference": {
            "id": "PMID:31251474",
            "description": "NM_032861.3:c.202C>T,NP_116250.3:p.(Arg68Ter) and NM_032861.3:c.129-1G>C. The authors report that analysis of mRNA from the patient's fibroblasts by RT\u2010PCR and subsequent sequencing indicated that the splicing site variant results in the skipping of exon 3 (PCR product of 61 bp vs. 100 bp for the wild type [WT]) and a new acceptor site at the beginning of exon 4 (c.131), resulting in a predicted protein with 14 amino acids deleted (codons 31 to 44, RNIIKFTGSLILGG), and the insertion of a serine, without a frameshift."
          }
        }
      ]
    },
    {
      "type": {
        "id": "HP:0012751",
        "label": "Abnormal basal ganglia MRI signal intensity"
      },
      "evidence": [
        {
          "evidenceCode": {
            "id": "ECO:0000033",
            "label": "author statement supported by traceable reference"
          },
          "reference": {
            "id": "PMID:31251474",
            "description": "NM_032861.3:c.202C>T,NP_116250.3:p.(Arg68Ter) and NM_032861.3:c.129-1G>C. The authors report that analysis of mRNA from the patient's fibroblasts by RT\u2010PCR and subsequent sequencing indicated that the splicing site variant results in the skipping of exon 3 (PCR product of 61 bp vs. 100 bp for the wild type [WT]) and a new acceptor site at the beginning of exon 4 (c.131), resulting in a predicted protein with 14 amino acids deleted (codons 31 to 44, RNIIKFTGSLILGG), and the insertion of a serine, without a frameshift."
          }
        }
      ]
    },
    {
      "type": {
        "id": "HP:0001943",
        "label": "Hypoglycemia"
      },
      "evidence": [
        {
          "evidenceCode": {
            "id": "ECO:0000033",
            "label": "author statement supported by traceable reference"
          },
          "reference": {
            "id": "PMID:31251474",
            "description": "NM_032861.3:c.202C>T,NP_116250.3:p.(Arg68Ter) and NM_032861.3:c.129-1G>C. The authors report that analysis of mRNA from the patient's fibroblasts by RT\u2010PCR and subsequent sequencing indicated that the splicing site variant results in the skipping of exon 3 (PCR product of 61 bp vs. 100 bp for the wild type [WT]) and a new acceptor site at the beginning of exon 4 (c.131), resulting in a predicted protein with 14 amino acids deleted (codons 31 to 44, RNIIKFTGSLILGG), and the insertion of a serine, without a frameshift."
          }
        }
      ]
    },
    {
      "type": {
        "id": "HP:0000365",
        "label": "Hearing impairment"
      },
      "evidence": [
        {
          "evidenceCode": {
            "id": "ECO:0000033",
            "label": "author statement supported by traceable reference"
          },
          "reference": {
            "id": "PMID:31251474",
            "description": "NM_032861.3:c.202C>T,NP_116250.3:p.(Arg68Ter) and NM_032861.3:c.129-1G>C. The authors report that analysis of mRNA from the patient's fibroblasts by RT\u2010PCR and subsequent sequencing indicated that the splicing site variant results in the skipping of exon 3 (PCR product of 61 bp vs. 100 bp for the wild type [WT]) and a new acceptor site at the beginning of exon 4 (c.131), resulting in a predicted protein with 14 amino acids deleted (codons 31 to 44, RNIIKFTGSLILGG), and the insertion of a serine, without a frameshift."
          }
        }
      ]
    },
    {
      "type": {
        "id": "HP:0012708",
        "label": "Reduced brain N-acetyl aspartate level by MRS"
      },
      "evidence": [
        {
          "evidenceCode": {
            "id": "ECO:0000033",
            "label": "author statement supported by traceable reference"
          },
          "reference": {
            "id": "PMID:31251474",
            "description": "NM_032861.3:c.202C>T,NP_116250.3:p.(Arg68Ter) and NM_032861.3:c.129-1G>C. The authors report that analysis of mRNA from the patient's fibroblasts by RT\u2010PCR and subsequent sequencing indicated that the splicing site variant results in the skipping of exon 3 (PCR product of 61 bp vs. 100 bp for the wild type [WT]) and a new acceptor site at the beginning of exon 4 (c.131), resulting in a predicted protein with 14 amino acids deleted (codons 31 to 44, RNIIKFTGSLILGG), and the insertion of a serine, without a frameshift."
          }
        }
      ]
    },
    {
      "type": {
        "id": "HP:0008947",
        "label": "Infantile muscular hypotonia"
      },
      "evidence": [
        {
          "evidenceCode": {
            "id": "ECO:0000033",
            "label": "author statement supported by traceable reference"
          },
          "reference": {
            "id": "PMID:31251474",
            "description": "NM_032861.3:c.202C>T,NP_116250.3:p.(Arg68Ter) and NM_032861.3:c.129-1G>C. The authors report that analysis of mRNA from the patient's fibroblasts by RT\u2010PCR and subsequent sequencing indicated that the splicing site variant results in the skipping of exon 3 (PCR product of 61 bp vs. 100 bp for the wild type [WT]) and a new acceptor site at the beginning of exon 4 (c.131), resulting in a predicted protein with 14 amino acids deleted (codons 31 to 44, RNIIKFTGSLILGG), and the insertion of a serine, without a frameshift."
          }
        }
      ]
    },
    {
      "type": {
        "id": "HP:0000252",
        "label": "Microcephaly"
      },
      "evidence": [
        {
          "evidenceCode": {
            "id": "ECO:0000033",
            "label": "author statement supported by traceable reference"
          },
          "reference": {
            "id": "PMID:31251474",
            "description": "NM_032861.3:c.202C>T,NP_116250.3:p.(Arg68Ter) and NM_032861.3:c.129-1G>C. The authors report that analysis of mRNA from the patient's fibroblasts by RT\u2010PCR and subsequent sequencing indicated that the splicing site variant results in the skipping of exon 3 (PCR product of 61 bp vs. 100 bp for the wild type [WT]) and a new acceptor site at the beginning of exon 4 (c.131), resulting in a predicted protein with 14 amino acids deleted (codons 31 to 44, RNIIKFTGSLILGG), and the insertion of a serine, without a frameshift."
          }
        }
      ]
    },
    {
      "type": {
        "id": "HP:0012157",
        "label": "Subcortical cerebral atrophy"
      },
      "evidence": [
        {
          "evidenceCode": {
            "id": "ECO:0000033",
            "label": "author statement supported by traceable reference"
          },
          "reference": {
            "id": "PMID:31251474",
            "description": "NM_032861.3:c.202C>T,NP_116250.3:p.(Arg68Ter) and NM_032861.3:c.129-1G>C. The authors report that analysis of mRNA from the patient's fibroblasts by RT\u2010PCR and subsequent sequencing indicated that the splicing site variant results in the skipping of exon 3 (PCR product of 61 bp vs. 100 bp for the wild type [WT]) and a new acceptor site at the beginning of exon 4 (c.131), resulting in a predicted protein with 14 amino acids deleted (codons 31 to 44, RNIIKFTGSLILGG), and the insertion of a serine, without a frameshift."
          }
        }
      ]
    },
    {
      "type": {
        "id": "HP:0200134",
        "label": "Epileptic encephalopathy"
      },
      "evidence": [
        {
          "evidenceCode": {
            "id": "ECO:0000033",
            "label": "author statement supported by traceable reference"
          },
          "reference": {
            "id": "PMID:31251474",
            "description": "NM_032861.3:c.202C>T,NP_116250.3:p.(Arg68Ter) and NM_032861.3:c.129-1G>C. The authors report that analysis of mRNA from the patient's fibroblasts by RT\u2010PCR and subsequent sequencing indicated that the splicing site variant results in the skipping of exon 3 (PCR product of 61 bp vs. 100 bp for the wild type [WT]) and a new acceptor site at the beginning of exon 4 (c.131), resulting in a predicted protein with 14 amino acids deleted (codons 31 to 44, RNIIKFTGSLILGG), and the insertion of a serine, without a frameshift."
          }
        }
      ]
    },
    {
      "type": {
        "id": "HP:0003688",
        "label": "Cytochrome C oxidase-negative muscle fibers"
      },
      "excluded": true,
      "evidence": [
        {
          "evidenceCode": {
            "id": "ECO:0000033",
            "label": "author statement supported by traceable reference"
          },
          "reference": {
            "id": "PMID:31251474",
            "description": "NM_032861.3:c.202C>T,NP_116250.3:p.(Arg68Ter) and NM_032861.3:c.129-1G>C. The authors report that analysis of mRNA from the patient's fibroblasts by RT\u2010PCR and subsequent sequencing indicated that the splicing site variant results in the skipping of exon 3 (PCR product of 61 bp vs. 100 bp for the wild type [WT]) and a new acceptor site at the beginning of exon 4 (c.131), resulting in a predicted protein with 14 amino acids deleted (codons 31 to 44, RNIIKFTGSLILGG), and the insertion of a serine, without a frameshift."
          }
        }
      ]
    },
    {
      "type": {
        "id": "HP:0003128",
        "label": "Lactic acidosis"
      },
      "evidence": [
        {
          "evidenceCode": {
            "id": "ECO:0000033",
            "label": "author statement supported by traceable reference"
          },
          "reference": {
            "id": "PMID:31251474",
            "description": "NM_032861.3:c.202C>T,NP_116250.3:p.(Arg68Ter) and NM_032861.3:c.129-1G>C. The authors report that analysis of mRNA from the patient's fibroblasts by RT\u2010PCR and subsequent sequencing indicated that the splicing site variant results in the skipping of exon 3 (PCR product of 61 bp vs. 100 bp for the wild type [WT]) and a new acceptor site at the beginning of exon 4 (c.131), resulting in a predicted protein with 14 amino acids deleted (codons 31 to 44, RNIIKFTGSLILGG), and the insertion of a serine, without a frameshift."
          }
        }
      ]
    },
    {
      "type": {
        "id": "HP:0003781",
        "label": "Excessive salivation"
      },
      "evidence": [
        {
          "evidenceCode": {
            "id": "ECO:0000033",
            "label": "author statement supported by traceable reference"
          },
          "reference": {
            "id": "PMID:31251474",
            "description": "NM_032861.3:c.202C>T,NP_116250.3:p.(Arg68Ter) and NM_032861.3:c.129-1G>C. The authors report that analysis of mRNA from the patient's fibroblasts by RT\u2010PCR and subsequent sequencing indicated that the splicing site variant results in the skipping of exon 3 (PCR product of 61 bp vs. 100 bp for the wild type [WT]) and a new acceptor site at the beginning of exon 4 (c.131), resulting in a predicted protein with 14 amino acids deleted (codons 31 to 44, RNIIKFTGSLILGG), and the insertion of a serine, without a frameshift."
          }
        }
      ]
    },
    {
      "type": {
        "id": "HP:0000750",
        "label": "Delayed speech and language development"
      },
      "evidence": [
        {
          "evidenceCode": {
            "id": "ECO:0000033",
            "label": "author statement supported by traceable reference"
          },
          "reference": {
            "id": "PMID:31251474",
            "description": "NM_032861.3:c.202C>T,NP_116250.3:p.(Arg68Ter) and NM_032861.3:c.129-1G>C. The authors report that analysis of mRNA from the patient's fibroblasts by RT\u2010PCR and subsequent sequencing indicated that the splicing site variant results in the skipping of exon 3 (PCR product of 61 bp vs. 100 bp for the wild type [WT]) and a new acceptor site at the beginning of exon 4 (c.131), resulting in a predicted protein with 14 amino acids deleted (codons 31 to 44, RNIIKFTGSLILGG), and the insertion of a serine, without a frameshift."
          }
        }
      ]
    },
    {
      "type": {
        "id": "HP:0001263",
        "label": "Global developmental delay"
      },
      "evidence": [
        {
          "evidenceCode": {
            "id": "ECO:0000033",
            "label": "author statement supported by traceable reference"
          },
          "reference": {
            "id": "PMID:31251474",
            "description": "NM_032861.3:c.202C>T,NP_116250.3:p.(Arg68Ter) and NM_032861.3:c.129-1G>C. The authors report that analysis of mRNA from the patient's fibroblasts by RT\u2010PCR and subsequent sequencing indicated that the splicing site variant results in the skipping of exon 3 (PCR product of 61 bp vs. 100 bp for the wild type [WT]) and a new acceptor site at the beginning of exon 4 (c.131), resulting in a predicted protein with 14 amino acids deleted (codons 31 to 44, RNIIKFTGSLILGG), and the insertion of a serine, without a frameshift."
          }
        }
      ]
    },
    {
      "type": {
        "id": "HP:0011968",
        "label": "Feeding difficulties"
      },
      "evidence": [
        {
          "evidenceCode": {
            "id": "ECO:0000033",
            "label": "author statement supported by traceable reference"
          },
          "reference": {
            "id": "PMID:31251474",
            "description": "NM_032861.3:c.202C>T,NP_116250.3:p.(Arg68Ter) and NM_032861.3:c.129-1G>C. The authors report that analysis of mRNA from the patient's fibroblasts by RT\u2010PCR and subsequent sequencing indicated that the splicing site variant results in the skipping of exon 3 (PCR product of 61 bp vs. 100 bp for the wild type [WT]) and a new acceptor site at the beginning of exon 4 (c.131), resulting in a predicted protein with 14 amino acids deleted (codons 31 to 44, RNIIKFTGSLILGG), and the insertion of a serine, without a frameshift."
          }
        }
      ]
    },
    {
      "type": {
        "id": "HP:0002307",
        "label": "Drooling"
      },
      "evidence": [
        {
          "evidenceCode": {
            "id": "ECO:0000033",
            "label": "author statement supported by traceable reference"
          },
          "reference": {
            "id": "PMID:31251474",
            "description": "NM_032861.3:c.202C>T,NP_116250.3:p.(Arg68Ter) and NM_032861.3:c.129-1G>C. The authors report that analysis of mRNA from the patient's fibroblasts by RT\u2010PCR and subsequent sequencing indicated that the splicing site variant results in the skipping of exon 3 (PCR product of 61 bp vs. 100 bp for the wild type [WT]) and a new acceptor site at the beginning of exon 4 (c.131), resulting in a predicted protein with 14 amino acids deleted (codons 31 to 44, RNIIKFTGSLILGG), and the insertion of a serine, without a frameshift."
          }
        }
      ]
    },
    {
      "type": {
        "id": "HP:0002120",
        "label": "Cerebral cortical atrophy"
      },
      "evidence": [
        {
          "evidenceCode": {
            "id": "ECO:0000033",
            "label": "author statement supported by traceable reference"
          },
          "reference": {
            "id": "PMID:31251474",
            "description": "NM_032861.3:c.202C>T,NP_116250.3:p.(Arg68Ter) and NM_032861.3:c.129-1G>C. The authors report that analysis of mRNA from the patient's fibroblasts by RT\u2010PCR and subsequent sequencing indicated that the splicing site variant results in the skipping of exon 3 (PCR product of 61 bp vs. 100 bp for the wild type [WT]) and a new acceptor site at the beginning of exon 4 (c.131), resulting in a predicted protein with 14 amino acids deleted (codons 31 to 44, RNIIKFTGSLILGG), and the insertion of a serine, without a frameshift."
          }
        }
      ]
    },
    {
      "type": {
        "id": "HP:0003535",
        "label": "3-Methylglutaconic aciduria"
      },
      "evidence": [
        {
          "evidenceCode": {
            "id": "ECO:0000033",
            "label": "author statement supported by traceable reference"
          },
          "reference": {
            "id": "PMID:31251474",
            "description": "NM_032861.3:c.202C>T,NP_116250.3:p.(Arg68Ter) and NM_032861.3:c.129-1G>C. The authors report that analysis of mRNA from the patient's fibroblasts by RT\u2010PCR and subsequent sequencing indicated that the splicing site variant results in the skipping of exon 3 (PCR product of 61 bp vs. 100 bp for the wild type [WT]) and a new acceptor site at the beginning of exon 4 (c.131), resulting in a predicted protein with 14 amino acids deleted (codons 31 to 44, RNIIKFTGSLILGG), and the insertion of a serine, without a frameshift."
          }
        }
      ]
    },
    {
      "type": {
        "id": "HP:0008936",
        "label": "Muscular hypotonia of the trunk"
      },
      "evidence": [
        {
          "evidenceCode": {
            "id": "ECO:0000033",
            "label": "author statement supported by traceable reference"
          },
          "reference": {
            "id": "PMID:31251474",
            "description": "NM_032861.3:c.202C>T,NP_116250.3:p.(Arg68Ter) and NM_032861.3:c.129-1G>C. The authors report that analysis of mRNA from the patient's fibroblasts by RT\u2010PCR and subsequent sequencing indicated that the splicing site variant results in the skipping of exon 3 (PCR product of 61 bp vs. 100 bp for the wild type [WT]) and a new acceptor site at the beginning of exon 4 (c.131), resulting in a predicted protein with 14 amino acids deleted (codons 31 to 44, RNIIKFTGSLILGG), and the insertion of a serine, without a frameshift."
          }
        }
      ]
    },
    {
      "type": {
        "id": "HP:0001332",
        "label": "Dystonia"
      },
      "evidence": [
        {
          "evidenceCode": {
            "id": "ECO:0000033",
            "label": "author statement supported by traceable reference"
          },
          "reference": {
            "id": "PMID:31251474",
            "description": "NM_032861.3:c.202C>T,NP_116250.3:p.(Arg68Ter) and NM_032861.3:c.129-1G>C. The authors report that analysis of mRNA from the patient's fibroblasts by RT\u2010PCR and subsequent sequencing indicated that the splicing site variant results in the skipping of exon 3 (PCR product of 61 bp vs. 100 bp for the wild type [WT]) and a new acceptor site at the beginning of exon 4 (c.131), resulting in a predicted protein with 14 amino acids deleted (codons 31 to 44, RNIIKFTGSLILGG), and the insertion of a serine, without a frameshift."
          }
        }
      ]
    },
    {
      "type": {
        "id": "HP:0012707",
        "label": "Elevated brain lactate level by MRS"
      },
      "evidence": [
        {
          "evidenceCode": {
            "id": "ECO:0000033",
            "label": "author statement supported by traceable reference"
          },
          "reference": {
            "id": "PMID:31251474",
            "description": "NM_032861.3:c.202C>T,NP_116250.3:p.(Arg68Ter) and NM_032861.3:c.129-1G>C. The authors report that analysis of mRNA from the patient's fibroblasts by RT\u2010PCR and subsequent sequencing indicated that the splicing site variant results in the skipping of exon 3 (PCR product of 61 bp vs. 100 bp for the wild type [WT]) and a new acceptor site at the beginning of exon 4 (c.131), resulting in a predicted protein with 14 amino acids deleted (codons 31 to 44, RNIIKFTGSLILGG), and the insertion of a serine, without a frameshift."
          }
        }
      ]
    }
  ],
  "interpretations": [
    {
      "id": "PMID:31251474-Snanoudj-2019-SERAC1-proband",
      "progressStatus": "SOLVED",
      "diagnosis": {
        "disease": {
          "id": "OMIM:614739",
          "label": "3-@METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKESYNDROME; MEGDEL"
        },
        "genomicInterpretations": [
          {
            "subjectOrBiosampleId": "proband",
            "interpretationStatus": "CAUSATIVE",
            "variantInterpretation": {
              "variationDescriptor": {
                "id": "clinvar:120184",
                "geneContext": {
                  "valueId": "ENSG00000122335",
                  "symbol": "SERAC1",
                  "alternateIds": [
                    "HGNC:21061",
                    "entrez:84947",
                    "ensembl:ENSG00000122335",
                    "symbol:SERAC1"
                  ]
                },
                "vcfRecord": {
                  "genomeAssembly": "GRCh37",
                  "chrom": "6",
                  "pos": "158571548",
                  "ref": "G",
                  "alt": "A"
                },
                "allelicState": {
                  "id": "GENO:0000135",
                  "label": "heterozygous"
                }
              }
            }
          },
          {
            "subjectOrBiosampleId": "proband",
            "interpretationStatus": "CAUSATIVE",
            "variantInterpretation": {
              "variationDescriptor": {
                "id": "6-158571622-C-G",
                "geneContext": {
                  "valueId": "ENSG00000122335",
                  "symbol": "SERAC1",
                  "alternateIds": [
                    "HGNC:21061",
                    "entrez:84947",
                    "ensembl:ENSG00000122335",
                    "symbol:SERAC1"
                  ]
                },
                "vcfRecord": {
                  "genomeAssembly": "GRCh37",
                  "chrom": "6",
                  "pos": "158571622",
                  "ref": "C",
                  "alt": "G"
                },
                "allelicState": {
                  "id": "GENO:0000135",
                  "label": "heterozygous"
                }
              }
            }
          }
        ]
      }
    }
  ],
  "metaData": {
    "created": "1970-01-01T00:00:00Z",
    "createdBy": "Hpo Case Annotator : 1.0.14-SNAPSHOT",
    "submittedBy": "HPO:probinson",
    "resources": [
      {
        "id": "hp",
        "name": "human phenotype ontology",
        "url": "http://purl.obolibrary.org/obo/hp.owl",
        "version": "2018-03-08",
        "namespacePrefix": "HP",
        "iriPrefix": "http://purl.obolibrary.org/obo/HP_"
      },
      {
        "id": "pato",
        "name": "Phenotype And Trait Ontology",
        "url": "http://purl.obolibrary.org/obo/pato.owl",
        "version": "2018-03-28",
        "namespacePrefix": "PATO",
        "iriPrefix": "http://purl.obolibrary.org/obo/PATO_"
      },
      {
        "id": "geno",
        "name": "Genotype Ontology",
        "url": "http://purl.obolibrary.org/obo/geno.owl",
        "version": "19-03-2018",
        "namespacePrefix": "GENO",
        "iriPrefix": "http://purl.obolibrary.org/obo/GENO_"
      },
      {
        "id": "ncbitaxon",
        "name": "NCBI organismal classification",
        "url": "http://purl.obolibrary.org/obo/ncbitaxon.owl",
        "version": "2018-03-02",
        "namespacePrefix": "NCBITaxon",
        "iriPrefix": "http://purl.obolibrary.org/obo/NCBITaxon_"
      },
      {
        "id": "eco",
        "name": "Evidence and Conclusion Ontology",
        "url": "http://purl.obolibrary.org/obo/eco.owl",
        "version": "2018-11-10",
        "namespacePrefix": "ECO",
        "iriPrefix": "http://purl.obolibrary.org/obo/ECO_"
      },
      {
        "id": "omim",
        "name": "Online Mendelian Inheritance in Man",
        "url": "https://www.omim.org",
        "version": "2018-03-08",
        "namespacePrefix": "OMIM",
        "iriPrefix": "https://omim.org/entry/"
      }
    ],
    "phenopacketSchemaVersion": "2.0.0"
  }
}